trump glp 1 medicare to Cover GLP-1 Drugs for as Little as $50 a Month Under Plan Novo and Lilly cut GLP-1

After the first Semaglutide GLP-1 injection, Troy Watson ensures patients at Set Point Medical Weight Loss Clinic receive detailed guidance on what to expect and how to manage the first few days

Semaglutide at the 2.4 mg dose (the maximum approved for weight management) produces roughly 15-17% body weight reduction in clinical trials

65 PignalosaF.DesiderioA.MirraP.NigroC.PerruoloG.UlianichL.et al (2021)

Orforglipron (Orfoglip), approved in 2025, is an oral GLP-1 agonist for obesity

Trulicity is also a once- weekly GLP-1 agonist that is ready-to-use without reconstitution in the same way that once- daily GLP-1 agonists already are

doi: 10.1172/JCI104130